Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31738206 | 1.00 | DRD1 (0.54) | DRD1HTR2A | |
| SCHEMBL709870 | 0.78 | DRD1 (0.58) | DRD1HTR2A | |
| SCHEMBL29867917 | 0.78 | DRD1 (0.58) | DRD1HTR2A | |
| SCHEMBL709261 | 0.75 | DRD1 (0.64) | DRD1 | |
| SCHEMBL29867522 | 0.75 | DRD1 (0.64) | DRD1 | |
| SCHEMBL12337520 | 0.75 | DRD1 (0.62) | DRD1 | |
| SCHEMBL21374252 | 0.74 | DRD1 (0.62) | DRD1 | |
| SCHEMBL30066813 | 0.74 | DRD1 (0.62) | DRD1 | |
| SCHEMBL15871415 | 0.74 | DRD1 (0.62) | DRD1 | |
| SCHEMBL20661508 | 0.73 | DRD1 (0.53) | DRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10173993-B2 | Process for the synthesis of sulfones and sulfonamides | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2019-01-08 | — | — | US | disclosed |
| US-20170166542-A1 | Process for the Synthesis of Sulfones and Sulfonamides | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2017-06-15 | — | — | US | disclosed |
| EP-3178811-A1 | A PROCESS FOR THE SYNTHESIS OF SULFONES AND SULFONAMIDES | COMMISSARIAT À L'ÉNERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES (FR) | 2017-06-14 | — | — | EP | disclosed |
| US-9579641-B2 | Aryl phosphines with fused ring ortho-alkoxy substitution | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-02-28 | — | — | US | disclosed |
| US-20160184811-A1 | ARYL PHOSPHINES WITH FUSED RING ORTHO-ALKOXY SUBSTITUTION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-06-30 | — | — | US | disclosed |
| US-8188302-B2 | Hydroamination of alkenes | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2012-05-29 | — | — | US | disclosed |
| US-20090156824-A1 | Hydroamination of Alkenes | BOARD OF TRUSTEES OF UNIVERSITY OF ILLINOIS (US) | 2009-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170166542-A1 | Process for the Synthesis of Sulfones and Sulfonamides | STS, SULT2A1, TST | DRD1 2604/4885HTR2A 3129/4885 |
| US-20090156824-A1 | Hydroamination of Alkenes | HRH3, HRH4, H1-3 | DRD1 715/4885HTR2A 2025/4885 |
| US-10173993-B2 | Process for the synthesis of sulfones and sulfonamides | STS, SULT2A1, TST | DRD1 2604/4885HTR2A 3129/4885 |
| US-20160184811-A1 | ARYL PHOSPHINES WITH FUSED RING ORTHO-ALKOXY SUBSTITUTION | ALK, PHOSPHO1, MPL | DRD1 3012/4885HTR2A 1487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.